Credit: FDA. Increased demand for the drug has resulted in supply interruptions. Saxenda (liraglutide) may be in short supply through the end of 2023, according to the Food and Drug Administration’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results